Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sandimmun 250mg/5ml concentrate for inf ampoules
0802020G0BBABAE
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | No data available |
|
Sandostatin 1mg/5ml solution for injection vials
0803043N0BBADAD
|
Sandostatin | Octreotide acetate | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.3mg/1ml solution for injection ampoules
0803043Q0BBAAAA
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.6mg/1ml solution for injection ampoules
0803043Q0BBABAB
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.9mg/1ml solution for injection ampoules
0803043Q0BBACAC
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 10mg inj vials
0803043Q0BBAGAG
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 20mg inj vials
0803043Q0BBADAD
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 30mg inj vials
0803043Q0BBAHAH
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 40mg inj vials
0803043Q0BBAEAE
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 60mg inj vials
0803043Q0BBAFAF
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Siltuximab 100mg powder for solution for infusion vials
0802040AMAAABAB
|
Siltuximab | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Siltuximab 400mg powder for solution for infusion vials
0802040AMAAAAAA
|
Siltuximab | Siltuximab | Malignant Disease and Immunosuppression | No data available |
|
Simulect 10mg inj vials
0802020D0BBABAB
|
Simulect | Basiliximab | Malignant Disease and Immunosuppression | No data available |
|
Simulect 20mg inj vials
0802020D0BBAAAA
|
Simulect | Basiliximab | Malignant Disease and Immunosuppression | No data available |
|
Simulect 20mg powder for solution for injection vials
0802020D0BBACAC
|
Simulect | Basiliximab | Malignant Disease and Immunosuppression | No data available |
|
Siponimod 1mg tablets
0802040BBAAACAC
|
Siponimod | Siponimod | Malignant Disease and Immunosuppression | No data available |
|
Siponimod 2mg tablets
0802040BBAAABAB
|
Siponimod | Siponimod | Malignant Disease and Immunosuppression | No data available |
|
Sirolimus 2mg/g gel
0802020U0AAAGAG
|
Sirolimus | Sirolimus | Malignant Disease and Immunosuppression | No data available |
|
Sodiofolin 100mg/2ml solution for injection vials
0801000X0BBAAAA
|
Sodiofolin | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Sodiofolin 400mg/8ml solution for injection vials
0801000X0BBABAB
|
Sodiofolin | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Sodiofolin 900mg/18ml solution for injection vials
0801000X0BBACAC
|
Sodiofolin | Disodium folinate | Malignant Disease and Immunosuppression | No data available |
|
Soltamox 10mg/5ml oral solution
0803041S0BLAAAJ
|
Soltamox | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Somatuline Autogel 120mg/0.5ml inj pre-filled syringes
0803043P0BBADAD
|
Somatuline | Lanreotide | Malignant Disease and Immunosuppression | No data available |
|
Somatuline Autogel 60mg/0.3ml inj pre-filled syringes
0803043P0BBABAB
|
Somatuline | Lanreotide | Malignant Disease and Immunosuppression | No data available |
|
Somatuline Autogel 90mg/0.3ml inj pre-filled syringes
0803043P0BBACAC
|
Somatuline | Lanreotide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.